miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis-Reference-Cited by-同舟云学术

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis

Published:2014-11-28 Issue:1 Volume:6 Page:494-509
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hsieh Tsung-Hua¹,Hsu Chia-Yi²,Tsai Cheng-Fang²,Long Cheng-Yu¹,Chai Chee-Yin³,Hou Ming-Feng⁴,Lee Jau-Nan¹,Wu Deng-Chyang⁵,Wang Shao-Chun⁶,Tsai Eing-Mei²⁷¹⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

2. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

3. Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

4. Department of General Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

5. Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

6. Department of Cancer Biology, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45267, USA

7. Center for Research Resources and Development, Kaohsiung Medical University, Kaohsiung 80708, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. of Potential Noncoding RNAs Related to Spinal Cord Injury Based on Competing Endogenous RNAs;Molecular Neurobiology;2024-05-29

2. Clinical importance of serum miRNA levels in breast cancer patients;Discover Oncology;2024-01-27

3. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions;Cancer Cell International;2024-01-10

4. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications;Biomolecules;2023-10-28

5. Clinical importance of serum miRNA levels in breast cancer patients;2023-10-20